Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **T-cell receptor beta constant 1 chain** (TRBC1) is the constant region of the beta chain of the αβ T-cell receptor, a membrane-anchored heterodimeric protein expressed on the surface of T lymphocytes[1][2][4][6]. The TCR complex recognizes antigenic peptides presented by major histocompatibility complex (MHC) molecules, triggering T-cell activation through associated CD3 signal transduction proteins[1][3][5]. TRBC1 is one of two highly homologous constant regions (TRBC1 and TRBC2) in humans that provide structural support to the beta chain. Research has shown that monoclonal antibodies can specifically detect TRBC1, enabling rapid assessment of T-cell clonality, especially relevant in T-cell malignancy diagnostics and monitoring[2]. The TCR beta chains and their constant regions play a central role in adaptive immunity, mediating the specificity and diversity of immune responses.
Monoclonal antibody targeting of TRBC1 for detection and potential therapeutic depletion of TRBC1-expressing T-cell clones[2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell receptor beta constant 1 chain (TRBC1).